- Home
- ATRC vs FPF Comparison
ATRC vs FPF Comparison
Compare ATRC & FPF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATRC
- FPF
- Stock Information
- Founded
- ATRC 2000
- FPF 2013
- Country
- ATRC United States
- FPF United States
- Employees
- ATRC N/A
- FPF N/A
- Industry
- ATRC Medical/Dental Instruments
- FPF Trusts Except Educational Religious and Charitable
- Sector
- ATRC Health Care
- FPF Finance
- Exchange
- ATRC Nasdaq
- FPF Nasdaq
- Market Cap
- ATRC 1.6B
- FPF 1.1B
- IPO Year
- ATRC 2005
- FPF N/A
- Fundamental
- Price
- ATRC $31.00
- FPF $18.85
- Analyst Decision
- ATRC Strong Buy
- FPF
- Analyst Count
- ATRC 10
- FPF 0
- Target Price
- ATRC $49.50
- FPF N/A
- AVG Volume (30 Days)
- ATRC 393.5K
- FPF 186.7K
- Earning Date
- ATRC 07-29-2025
- FPF 01-01-0001
- Dividend Yield
- ATRC N/A
- FPF 8.08%
- EPS Growth
- ATRC N/A
- FPF N/A
- EPS
- ATRC N/A
- FPF N/A
- Revenue
- ATRC $480,076,000.00
- FPF N/A
- Revenue This Year
- ATRC $14.63
- FPF N/A
- Revenue Next Year
- ATRC $12.62
- FPF N/A
- P/E Ratio
- ATRC N/A
- FPF N/A
- Revenue Growth
- ATRC 15.79
- FPF N/A
- 52 Week Low
- ATRC $20.20
- FPF $13.91
- 52 Week High
- ATRC $43.11
- FPF $18.09
- Technical
- Relative Strength Index (RSI)
- ATRC 42.67
- FPF 67.76
- Support Level
- ATRC $30.49
- FPF $18.74
- Resistance Level
- ATRC $32.44
- FPF $18.93
- Average True Range (ATR)
- ATRC 0.93
- FPF 0.12
- MACD
- ATRC -0.09
- FPF -0.00
- Stochastic Oscillator
- ATRC 23.12
- FPF 89.92
About ATRC AtriCure Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
About FPF First Trust Intermediate Duration Preferred & Income Fund of Beneficial Interest
First Trust Inter Dur Pref& Income Fund is a diversified, closed-end management investment company. Its primary investment objective is to seek a high level of current income. Further, it has a secondary objective of capital appreciation. The Fund invests in the traditional preferred securities, hybrid preferred securities, floating rate & fixed-to-floating rate preferred securities, debt securities, convertible securities, and contingent convertible securities issued by U.S. and non-U.S. companies. Its investment portfolio includes industries such as Banks, Insurance, Capital Markets, Electric Utilities, Oil, Gas & Consumable Fuels, Food Products, and others.